J J Ott

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. doi Long-term protective effects of hepatitis A vaccines. A systematic review
    Jördis Jennifer Ott
    World Health Organization, 20, Avenue Appia, 1211, Geneva 27, Switzerland
    Vaccine 31:3-11. 2012
  2. pmc The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
    Jördis J Ott
    World Health Organization, Geneva, Switzerland
    BMC Infect Dis 12:131. 2012
  3. doi The importance of early symptom recognition in the context of early detection and cancer survival
    J J Ott
    Noncommunicable diseases and Mental Health Cluster, World Health Organisation, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Eur J Cancer 45:2743-8. 2009
  4. ncbi Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations
    J J Ott
    World Health Organization, 20, Avenue Appia, 1211 Geneva 27, Switzerland Helmholtz Centre for Infection Research, Department of Epidemiology, Braunschweig, Germany Electronic address
    Int J Infect Dis 17:e939-44. 2013
  5. doi Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity
    J J Ott
    World Health Organization, 20, Avenue Appia, 1211 Geneva 27, Switzerland
    Vaccine 30:2212-9. 2012
  6. doi Global cancer incidence and mortality caused by behavior and infection
    J J Ott
    World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    J Public Health (Oxf) 33:223-33. 2011

Detail Information

Publications6

  1. doi Long-term protective effects of hepatitis A vaccines. A systematic review
    Jördis Jennifer Ott
    World Health Organization, 20, Avenue Appia, 1211, Geneva 27, Switzerland
    Vaccine 31:3-11. 2012
    ..Limitations in data availability and implications for future research in this area are discussed...
  2. pmc The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
    Jördis J Ott
    World Health Organization, Geneva, Switzerland
    BMC Infect Dis 12:131. 2012
    ..The risk of developing chronic HBV infection and liver disease is highest at young age. Our aim was to assess perinatal HBV transmission risk by means of estimating age- and region-specific HBeAg prevalence...
  3. doi The importance of early symptom recognition in the context of early detection and cancer survival
    J J Ott
    Noncommunicable diseases and Mental Health Cluster, World Health Organisation, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Eur J Cancer 45:2743-8. 2009
    ....
  4. ncbi Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations
    J J Ott
    World Health Organization, 20, Avenue Appia, 1211 Geneva 27, Switzerland Helmholtz Centre for Infection Research, Department of Epidemiology, Braunschweig, Germany Electronic address
    Int J Infect Dis 17:e939-44. 2013
    ..Our objective was to identify evidence on the protection achieved by single-dose use of inactivated hepatitis A vaccines in order to evaluate the potential of a flexible booster administration in the form of a second dose...
  5. doi Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity
    J J Ott
    World Health Organization, 20, Avenue Appia, 1211 Geneva 27, Switzerland
    Vaccine 30:2212-9. 2012
    ..We estimate age-, sex- and region-specific prevalence of chronic HBV infection and calculate the absolute number of persons being chronically infected...
  6. doi Global cancer incidence and mortality caused by behavior and infection
    J J Ott
    World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    J Public Health (Oxf) 33:223-33. 2011
    ....